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Comprehensive, computerized databases of cellular protein information derived from the analysis of two-dimensional 
gels, together with recently developed techniques to microsequence proteins offer a new dimension to the study of genome 
organization and function. In particular, human protein databases provide an ideal framework in which to focus the 
human genome sequencing effort. 
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1. INTRODUCTION 
Since its development in 1975 [ 11, high resolu- 
tion 2D gel electrophoresis has provided a unique 
tool to examine the protein composition and 
overall patterns of gene expression of a given cell 
type ([2,3] and references therein). About 2000 
proteins can be separated using this technology, a 
number that corresponds to about 2 million base 
pairs of coded DNA. Much of the information 
generated so far however, has not reached the 
scientific community in its fullness, and only 
recently thanks to the development of appropriate 
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computer software (reviewed in [4]), it has been 
possible to scan, assign numbers to individual 
polypeptides, compare, quantitate and store the 
wealth of information contained in the gels. This 
important development has allowed us to make 
full use of existing data, and to construct com- 
prehensive, computerized databases of cellular 
protein information ([3-81 and references therein). 
Human protein databases [6,7] are becoming in- 
creasingly important in view of the concerted ef- 
fort to map and sequence the entire human 
genome. Some features of these databases as well 
as recent technical developments concerning pro- 
tein microsequencing are briefly discussed below. 
2. COMPRENSIVE, COMPUTERIZED 
DATABASES OF HUMAN CELLULAR 
PROTEINS 
To date, three databases of human cellular pro- 
teins (transformed epithelial amnion cells (AMA) 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
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Fig. 1. Synth etic 
FEBS LETTERS February 1989 
images of IEF gels of [35S]methionine-labelled AMA cellular proteins showing protein names 
numbers (lower panel). Only a fraction of the gel is shown. 
(WI Per and 
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[6], peripheral blood mononuclear cells (PBMC) 
[6], and embryonic lung MRC-5 fibroblasts [7]) 
have been published in a comprehensive form. 
Some important features of these databases are ex- 
emplified here using data from the master AMA 
database [6]. In this database a total of one thou- 
sand seven hundred and eighty-two [3sS]methio- 
nine-labelled polypeptides have been separated 
(fig. 1, upper panel; only a fraction of the IEF syn- 
thetic image is shown) and recorded using com- 
puter analyzed two-dimensional gel electrophoresis 
(PDQUEST) [9]. Each polypeptide has been 
assigned a number (fig. 1, lower panel), and 
various categories have been created to enter 
qualitative (annotations, fig. 1, upper panel) and 
quantitative data (fig.2, quantitations of tropomy- 
osins in normal and SV40 transformed human 
MRC-5 fibroblasts) [7]. In general, categories or 
entries are created so as to compile information 
concerning physical, chemical, biochemical, phy- 
siological, genetic, architectural and biological 
properties of proteins. Table 1 gives an example of 
some of the entries available for the cell cycle 
regulated and DNA replication protein cyclin/ 
PCNA (see also fig. 1, upper panel) [6]. This 
proliferation-sensitive nuclear protein was one of 
the first interesting polypeptides identified using 
the 2D gel technology [lo]. 
Clearly, computerized, comprehensive data- 
bases allow easy access to a large body of data 
and provide an efficient medium to communicate 
standardized protein information. Once a protein 
is identified in a database, all of the information 
accumulated, can be easily retrieved and made 
available to the researcher. 
Databases will evolve as more proteins are iden- 
tified (comigration with purified proteins, im- 
munoblotting using specific antibodies, compari- 
Fig.2. Synthetic image of a fraction of an IEF fluorogram of [“‘S]methionine-labelled proteins from normal human embryonic lung 
MRC-5 fibroblasts (p35). The histograms how levels of synthesis of tropomyosins in MRC-5 (left bar) and MRC-5 SV40 (MRCS-V2) 
(right bar) human embryonal ung fibroblasts. The height of the bars is scaled to the maximum detected value. 
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Table 1 
Entries for cyclin/PCNA in the human AMA protein databasea 
February 1989 
Entries for cyclin/PCNA 
Protein 9218 
Information entered 
DNA sequence 
Amino acid sequence 
Subcellular localization 
Function 
Phosphorylation 
Synthesis in proliferating and non-proliferating cells 
Cell cycle specificity 
Presence in various vertebrate species 
Coregulated proteins 
Variants 
Presence in adult human tissues 
Presence in fetal human tissues 
Antibodies produced against protein 
Antibodies detected in human sera 
Associated proteins 
Cell type in which highest expression has been 
observed so far 
Purification procedure 
Effects of drugs 
HeLa protein catalogue number 
Mouse protein catalogue number 
Known [24] 
Known. Deduced from DNA sequence [24] 
Nuclear. Sites of DNA replication [25]. Nuclear patterns of cyclin/ 
PCNA antigen staining subdivide S phase [26] 
Some step in DNA replication [25,27]. Coordinated expression of 
leading and lagging strand [28]. Also a role in DNA repair [29] 
Not phosphorylated [6] 
Synthesized mainly by proliferating cells of both normal and 
transformed origin ([30] and references therein) 
Preferentially synthesized uring S-phase. Increased synthesis tarts at 
the G/S transition border [lo] 
Present in aves, bat, dog, dolphin, goat, hamster, human, mink, 
monkey, mouse, Pisces, potoroo, rabbit and rat ([31] and references 
therein) 
A few have been identified by Carrels and Franza in rat REF52 cells [8] 
Two. One more acidic variant present in hamster, human, potoroo and 
rat, and the other more basic present in mouse ([31] and references 
therein) 
Not detected in the following tissues: aorta, bladder, cavum oris, 
cerebellar cortex, cerebral cortex, cornea, ductus deferens, epididymis, 
fat tissue, heart muscle, kidney cortex, kidney medulla, larynx, lung, 
mammary gland, medulla oblongata, mesencephalon, palate, pharynx, 
posterior eye polus, prostata, rectum, skeletal muscle, skin, 
submaxillary glands, thyroid gland, trachea, ureter, uterus, veins, and 
vesicular seminalis [32] 
Small intestine, thymus, spleen, kidney, liver and lung exhibit high 
levels of cyclin/PCNA ([a], see also [33] for data on mouse tissues) 
Monoclonals [34] and rabbit polyclonal antibodies ([35], unpublished 
observations of Gesser, B., Basse, B. and Celis, J.E.) 
In a few percentages of patients with Systemic Lupus Erythematosus 
WI 
Associated with DNA polymerase 6 [35,37,38] 
Human Molt-4 cells [30] 
Available in article by Ogata et al. [39] 
Cyclin/PCNA synthesis is not affected by aphidicolin or hydroxyurea 
]401 
IEF 49 [41] 
IEF Slf [42] 
a Modified from Celis et al. [6] 
son of peptide sequences to sequences tored in 
protein databanks (see below)), and new informa- 
tion, gathered worldwide, is entered in the form of 
annotations. Colleagues are encouraged to send us 
250 
samples of purified human proteins and/or anti- 
bodies (broad species specificity) that could be 
used to identify new proteins. 
Comprehensive human databases may become 
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important tools for the study of diseases, and may 
provide an ideal framework in which to focus the 
human genome mapping and sequencing effort. 
3. MICROSEQUENCING HAS ADDED A 
NEW DIMENSION TO COMPREHENSIVE 
HUMAN PROTEIN DATABASES 
One of the major problems encountered in 
building databases based on the analysis of two- 
dimensional gels is the identification and 
characterization of the large number of proteins 
separated by this technology. Here, protein 
microsequencing may come into play. Indeed, 
generated pieces of protein sequences can be com- 
pared with available sequences tored in databanks 
in order to identify known proteins. 
The development of highly sensitive amino acid 
gas-phase or liquid-phase sequenators [ 1 I], 
together with the establishment of very efficient 
protein and peptide sample preparation methods, 
have opened the possibility to carry out a 
systematic sequence analysis of proteins resolved 
by 2D gel electrophoresis. Already in the early 
seventies, gel electrophoresis was used to purify 
proteins for sequencing purposes (reviewed by 
Weber and Osborn in [12]). Here, proteins were 
recovered by diffusion and sequenced by the 
manual dansyl-Edman degradation (already!) at 
the nanomole ( f 50 pug) level. This new technique 
was further refined by using electro-elution to 
recover proteins and by miniaturizing the system 
[ 131. This method has been used extensively, but 
showed increasing drawbacks (low yields, protein 
samples contaminated by free amino acids, and 
NH*-terminal blocking) as the amounts of handled 
protein became gradually smaller (e.g. at the 10 
picomole level). 
Most of these problems have been minimized 
with the introduction of protein-electroblotting 
procedures [ 14-181. When proteins are blotted on 
chemically inert membranes, it is possible to se- 
quence the immobilized proteins directly without 
additional manipulations. Thus, depending on the 
amount of bound protein and its nature, this direct 
sequencing procedure generally yields NHz-termi- 
nal sequences containing lo-40 residues. As such, 
this technique was employed to identify, by their 
NHz-terminal sequences, differentially expressed 
major proteins from total cellular extracts se- 
parated on 2D gels 115,161. Although t e method 
was technically simple and therefore very popular, 
many laboratories have faced unacceptably high 
levels of artefactual NHz-terminal blocking with 
gel separated proteins. By carrying out gel elec- 
trophoresis with buffers of lower pH, initial se- 
quencing yields could be improved, suggesting that 
the NHz-terminal blockage takes place during gel 
electrophoresis, most likely, due to reaction with 
unpolymerized acrylamide [ 191. In addition to 
these technical problems, many proteins are 
blocked in vivo by acylation or by a pyrrolidone 
carboxylic acid cap. 
The problem of NH?-terminal blocking can be 
circumvented by cleaving the protein and 
generating internal sequences. This can be ac- 
complished by fragmenting the protein while pre- 
sent in the gel (gel in situ cleavage), or by cleaving 
it while bound to the membrane (membrane in situ 
cleavage) [20-221. In both cases, proteins are 
either cleaved in a restricted way (e.g. by limited 
enzymatic digestion or by using restriction 
chemical cleavage conditions), or fragmented into 
smaller peptides. In the first case, the large 
fragments obtained are separated again by gel- 
electrophoresis, but in the second situation, 
generated peptides are too small for gel elec- 
trophoresis and must be purified by reverse-phase 
HPLC. 
Of the different combinations examined, we ex- 
perienced very good results by using exhaustive 
proteolytic digestion on membrane-immobilized 
proteins. This method has been described for 
Ponceau red-stained proteins on nitrocellulose 
blots [21], for Amido-black-stained Immobilon- 
bound proteins, and for fluorescamine-detected 
proteins on glass-fiber membranes [22]. The pro- 
teases used (trypsin, chymotrypsin or pepsin) 
cleave at multiple sites, generating small peptides 
which elute from the blot into the digestion buffer 
from which they are purified by reverse-phase 
HPLC before being sequenced individually. 
Although each of these manipulations could be ex- 
pected to result in a reduced yield of final sequence 
information, we noticed much to our surprise, that 
the peptides could be sequenced with high efficien- 
cy. In our hands, this approach could be routinely 
applied to gel purified proteins available in 
amounts ranging from 5 to 10 pg, and often yield- 
ed sequence information covering more than 30% 
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Fig.3. Internal sequences identifying protein IEF9109 [6,7] as a human non-muscle tropomyosin. Tryptic peptides obtained by 
membrane in situ cleavage were separated on a C4 (4.6 x 250 mm) reverse-phase column (Vydac Separations Group, USA). Solvent 
A consisted of 0.1% TFA, and solvent B was 70% acetonitrile in 0.1% TFA. A gradient from 0% solvent B to 100% solvent B was 
applied in a linear mode over 70 min. The eluate (1 ml/min) was recorded by absorbancy at 214 nm (0.2 AUFS) (upper panel). 0 
indicates the start of the chromatogram. Peptides were collected manually in Eppendorf tubes. Those indicated by arrows were 
subjected to gas-phase sequence analysis using a 470 A Applied Biosystems Inc. (USA) gas-phase sequenator equipped with a 120 A 
on-line PTH-amino acid analyzer. As an illustration, the PTH-residue chromatograms of cycles 1-15 of peak number 5 are shown. 
Assigned residues are indicated by the one-letter notation (lower panel). 
of the total protein. As membrane-immobilized 
proteins are not homogeneously digested, but 
rather show protease sensitivity next to resistant 
regions, the number of peptides generated is much 
lower than theoretically expected from the number 
of potential cleavage sites. Consequently, HPLC 
peptide chromatograms are less complex and the 
majority of the peptides can be recovered in pure 
form. 
As only limited amounts of a protein mixture 
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can be loaded on a 2D gel, proteins of interest are 
often obtained in yields which are insufficient for 
the currently available sequencing technology. 
More material can be obtained by enriching for a 
certain subcellular fraction (purified cell 
organelles) or by exploiting affinity (dyes, metals, 
drugs, etc.) or hydrophobic properties of proteins 
prior to gel analysis. 
Alternatively, spots cut from several gels can be 
combined and the protein re-eluted. In the example 
shown in fig.3, protein IEF9109 (see also fig.2) 
[6,7] was eluted from 10 gel pieces cut from 2D gels 
of human Molt-4 proteins. The gels had been stain- 
ed with Coomassie blue according to standard pro- 
cedures and dried. In this form, gel pieces can be 
stored for several months or even mailed to 
laboratories having amino acid sequence facilities. 
The gel pieces were then further processed by 
allowing them to re-swell in buffer and placed in a 
slot (1.5 mm thick, 6 mm broad and 30 mm deep) 
of a 1D gel. Using the stacking potential of the 
discontinuous gel system, the protein was eluted 
and re-concentrated as a sharp band in the second 
gel. After electroblotting onto membranes, the 
protein was digested with trypsin and the peptides 
were separated by reverse-phase HPLC (fig.3, up- 
per panel) and collected individually for sequence 
determination on a gas-phase sequenator. Com- 
parison of sequence data from two of the peptides 
(the sequences of peptides 5 and 16 were 
YSEKEDKYEEEIK [fig.3, lower panel] and EEN- 
VGLHQTLDQTLNELNXI, respectively), with se- 
quences stored in the PIR databank, indicated that 
this protein corresponds to a tropomyosin (align- 
ing with residues 177-189 and 228-247 of human 
fibroblast tropomyosin). This is in agreement with 
previous studies which showed that this protein is 
immunoprecipitated by a monoclonal antibody 
that reacts with several human tropomyosins [23]. 
In summary, the membrane in situ proteolytic 
degradation technique is particularly adapted for 
sequence analysis of picomolar amounts of pro- 
teins and exhibits several advantages over other 
techniques able to generate internal sequences: (i) 
proteins are digested for a short period of time 
with a small amount of protease, thus limiting the 
formation of protease-derived peptides due to 
autodigestion and (ii) peptides that originate from 
protease-sensitive regions in the protein are ob- 
tained in high yields and can be sequenced with 
high efficiency. As far as we can judge, this 
method avoids most of the drawbacks associated 
with alternative procedures, and may be con- 
sidered as the most suitable for obtaining pieces of 
internal sequences for protein comparison, or for 
isolation and sequencing of the corresponding 
cDNA clones. All available information indicates 
that it may be possible to obtain partial sequence 
information from most of the proteins resolved by 
2D gels that can be visualized by Coomassie blue 
staining. Indeed, several proteins (catalogued in 
the AMA protein database) recovered from 2D 
gels have been microsequenced so far using this 
procedure (Bauw et al., in preparation). 
4. FROM PROTEINS TO CLONED GENES: 
HUMAN DATABASES AND THEIR 
IMPLICATION FOR THE STUDY OF GENE 
ORGANIZATION AND FUNCTION 
Comprehensive human protein databases offer 
an inventory of thousands of proteins many of 
which are of unknown function. As more proteins 
are identified, and new information is gathered 
worldwide, databases will display overall patterns 
of gene expression and will encourage a global ap- 
proach to. the cell. Most importantly, databases 
may pinpoint individual or groups of polypeptides 
(coregulated proteins) that may exhibit interesting 
regulatory patterns and that may help to focus the 
human genome mapping and sequencing effort. 
In our laboratories, work will be mainly concen- 
trated on the study of proliferation-sensitive pro- 
teins ([7] and references therein) as well as 
cytoskeletal components associated with actin. In 
the first instance, oligonucleotide probes prepared 
from information obtained from partial peptide 
sequences, as well as specific antibodies will be us- 
ed to clone the cDNAs. These in turn could be used 
to quantitate message expression, and to screen 
genomic libraries in an effort to identify regulatory 
sequences that may be present in groups of pro- 
teins that are coregulated. 
In the long run, as human genome sequence data 
will progressively become available, it will also be 
possible to assign partial protein sequences to 
genes for which the full DNA sequence and the 
chromosomal location is known. In this context, 
microsequencing of 2D gel purified proteins may 
function as the indispensable link between the 2D 
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gel cellular protein databases and information 
derived from systematic sequencing of the human 
genome . 
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